Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Condition: Relapsed and Refractory Multiple Myeloma Interventions: Drug: Mezigdomide; Drug: Ixazomib; Drug: Dexamethasone Sponsors: Kathleen Dorritie; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials